Louisville, KY (Scicasts) – Grapefruits have long been known for their health benefits, and the subtropical fruit may revolutionize how medical therapies like anti-cancer drugs are delivered to specific tumour cells.
Singapore (Scicasts) – Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Houston, TX (Scicasts) – Environment is not the only factor in shaping regulatory patterns -- and it might not even be the primary factor, according to a new Rice University study that looks at how cells' protein networks relate to a bacteria's genome.
Cambridge, MA (Scicasts) – Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments has drawbacks, including the risk of side effects.
London UK (Scicasts) – Researchers from King's College London have used a novel form of MRI to identify crucial developmental processes in the brain that are vulnerable to the effects of premature birth. [Video]
Columbus, OH (Scicasts) – New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells’ “superpower” to escape death.
Philadelphia, PA (Scicasts) – The allure of personalized medicine has made new, more efficient ways of sequencing genes a top research priority. One promising technique involves reading DNA bases using changes in electrical current as they are threaded through a nanoscopic hole.
Japan (Scicasts) – In our interaction with our environment we constantly refer to past experiences stored as memories to guide behavioural decisions. But how memories are formed, stored and then retrieved to assist decision-making remains a mystery.
New York, NY (Scicasts) – In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual cells.
Phoenix, AZ (Scicasts) – In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.
Singapore and Schlieren (Zurich), Switzerland (Scicasts) – Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG have announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology.
Munich, Germany (Scicasts) – Infections can trigger haematopoiesis at sites outside the bone marrow – in the liver, the spleen or the skin. LMU researchers now show that a specific type of immune cell facilitates such “extra medullary” formation of blood cells.
Orlando, FL (Scicasts) – A team of researchers from several universities – including UCF –has observed a rare quantum physics effect that produces a repeating butterfly-shaped energy spectrum in a magnetic field, confirming the longstanding prediction of the quantum fractal energy structure called Hofstadter's butterfly.
Cambridge, MA (Scicasts) – Injectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin.
Berlin, Germany (Scicasts) – Classical X-ray radiographs provide information about internal, absorptive structures of organisms such as bones. Alternatively, X-rays can also image soft tissues throughout early embryonic development of vertebrates.
Worcester, MA (Scicasts) – Findings from two new cancer studies yield the best evidence yet that cancer may be better defined by its genetics than the organ in which it originates. These new findings will impact both research and treatment at UMass Medical School and the UMass Memorial Cancer Center of Excellence. [Video]
Philadelphia, PA (Scicasts) – In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.